510(k) Report

510(k) · Cleared

Cleared

HG PRO XP Nitrile Powder Free Examination Gloves Tested for Use with Chemotherapy Drugs

K162381510(k) TraditionalCleared Jan 31, 2017160-day reviewClass I21 CFR 880.6250

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Healthy Glove Co., Ltd. · LZA Polymer Patient Examination Glove

Cleared on Jan 31, 2017 as substantially equivalent to K113423 (Kimberly-Clark Corp., 2012) after a 160-day review. Its family tree reaches back 4 generations to 2005.

Decided
Jan 31, 2017
Review
160 days
Class
Class I
Product code
LZA
Recalls
None
Predicates
1

Its longest line of descent runs back 4 generations to K051347 (2005). 10 ancestors in all, the oldest K992062 (1999). No later device cites it as a predicate yet.

  1. Root · 4 generations backK051347 Kimberly-Clark* Sterling* Nitrile Powder-Free Examination GloveKimberly-Clark Corp. · 2005
  2. 3 generations backK081260 Kimberly-Clark *Lavender* Nitrile Power-Free Exam GlovesKimberly-Clark Corp. · 2008
  3. 2 generations backK101596 Kimberly-Clark Purple Nitrile Powder-Free Exam Glove (Chemotherapy…Kimberly-Clark · 2010
  4. 1 generation backK113423 Kimberly Clark Purple Nitrile, and Purple Nitrile Xtra Powder Free…Kimberly-Clark Corp. · 2012
  5. This deviceK162381 HG PRO XP Nitrile Powder Free Examination Gloves Tested for Use with…Healthy Glove Co., Ltd. · 2017
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K051347Kimberly-Clark* Sterling* Nitrile Powder-Free Examination GloveKimberly-Clark Corp.2005—
−3K081260Kimberly-Clark *Lavender* Nitrile Power-Free Exam GlovesKimberly-Clark Corp.2008—
−2K101596Kimberly-Clark Purple Nitrile Powder-Free Exam Glove (Chemotherapy Glove) and…Kimberly-Clark2010—
−1K113423Kimberly Clark Purple Nitrile, and Purple Nitrile Xtra Powder Free Exam GloveKimberly-Clark Corp.2012—
0 (this device)K162381HG PRO XP Nitrile Powder Free Examination Gloves Tested for Use with…Healthy Glove Co., Ltd.2017—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199920
200410
200820
201010
FIG. 1 — Lineage of K162381, 2005–2017Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LZA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LZA device

  1. #1 K192333 Blue Nitrile Examination Gloves Powder Freescore 71.0 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K113423Kimberly Clark Purple Nitrile, and Purple Nitrile Xtra Powder Free Exam Glove
Summary page 5
…Kimberly Clark Corporation Device Name: PURPLE NlTRlLE-XTRA* Powder-Free Exam - 12' Length 510(k): K113423 Regulatory Class: I Classification Name: Patient Examination Gloves (21 CFR 880.62…
Kimberly-Clark Corp.2012—

Also cleared against K113423: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 12 years and passes through 3 companies; a new generation was cleared every 3.1 years on median.
  • 1 of the 10 ancestors has a recall of any class.
  • 2 other devices also cite its predicate K113423.

How does its category compare?

All LZA devices

LZA Polymer Patient Examination Glove: FDA decisions, review times, recalls and adverse event reports over 20 years. 2017, this device’s year, is highlighted.

FDA decisions per year · LZA

24in 2025

2007: 212008: 182009: 282010: 312011: 262012: 332013: 202014: 272015: 202016: 302017: 442018: 222019: 252020: 302021: 1392022: 1462023: 622024: 302025: 242026 (partial year): 15
2007high 146 (2022) · low 18 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LZA

110in 2025

2007: 95 days median2008: 97 days median2009: 112 days median2010: 97 days median2011: 122 days median2012: 110 days median2013: 130 days median2014: 197 days median2015: 112 days median2016: 171 days median2017: 124 days median2018: 178 days median2019: 212 days median2020: 101 days median2021: 111 days median2022: 111 days median2023: 92 days median2024: 89 days median2025: 110 days median2026 (partial year): 103 days median
2007high 212 (2019) · low 89 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LZA

3so far in 2026, the most since 2007

2015: 12016: 12026 (partial year): 3
2007high 3 (2026) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LZA

73in 2025

2007: 72008: 22009: 122010: 122011: 92012: 112013: 102014: 82015: 122016: 252017: 42018: 32019: 212020: 42021: 202022: 192023: 242024: 762025: 73
2007high 76 (2024) · low 2 (2008)2025

MAUDE reports naming product code LZA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007219507
2008189702
200928112012
20103197012
20112612209
201233110011
201320130010
20142719708
201520112112
201630171125
20174412404
20182217803
201925212021
20203010104
2021139111020
2022146111019
20236292024
20243089076
202524110073
2026151033—

What is it indicated for?

A powder-free patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand or finger to prevent contamination between patient and examiner. In addition, these gloves were tested for use with the following chemotherapy drugs at specific concentrations as per ASTM D6978-035 Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs. The gloves have been tested with the…

Read the full statement (329 words)

A powder-free patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand or finger to prevent contamination between patient and examiner.

In addition, these gloves were tested for use with the following chemotherapy drugs at specific concentrations as per ASTM D6978-035 Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs.

The gloves have been tested with the following drugs and the respective breakthrough detection times are listed below.

Blenoxane (15 mg/ml) — > 240 minutes

Busulfan (6 mg/ml) — > 240 minutes

Carboplatin (10 mg/ml) — > 240 minutes

Carmustine (BCNU) (3.3 mg/ml) — 30.4 minutes

Cisplatin (1.0 mg/ml) — > 240 minutes

Cyclophosphamide (Cytoxan) (20 mg/ml) — > 240 minutes

Cytarabine (100 mg/ml) — > 240 minutes

Dacarbazine (DTIC) (10.0 mg/ml) — > 240 minutes

Daunorubicin (3 mg/ml) — > 240 minutes

Docetaxel (10.0 mg/ml) — > 240 minutes

Doxorubicin Hydrochloride (2.0 mg/ml) — > 240 minutes

Ellence (2 mg/ml) — > 240 minutes

Etoposide (Toposar) (20.0 mg/ml) — > 240 minutes

Fludarabine (25 mg/ml) — > 240 minutes

Fluorouracil (50.0 mg/ml) — > 240 minutes

Ganciclovir (10 mg/ml) — > 240 minutes

Gemcitabine (Gemzar) (38 mg/ml) — > 240 minutes

Idarubicin (1 mg/ml) — > 240 minutes

Ifosfamide (50.0 mg/ml) — > 240 minutes

Irinotecan (20.0 mg/ml) — > 240 minutes

Mechlorethamine HCI (1.0 mg/ml) — > 240 minutes

Melphalan (3 mg/ml) — > 240 minutes

Methotrexate (25 mg/ml) — > 240 minutes

Mitoxantrone (2.0mg/ml) — > 240 minutes

Mitomycin C (0.5 mg/ml) — > 240 minutes

Oxaliplatin (3 mg/ml) — > 240 minutes

Paclitaxel (Taxol) (6.0 mg/mi) — > 240 minutes

Rituximab (10 mg/ml) — > 240 minutes

Thiotepa (10.0 mg/ml) — > 240 minutes

Trisenox (0.1 mg/ml) — > 240 minutes

Vincristine Sulfate (1.0 mg/ml) — > 240 minutes

Vinorelbine (10 mg/ml) — > 240 minutes

Please note that the following drug has extremely low permeation time:

Carmustine (BCNU) (3.3 mg/ml) at 30.4 minutes

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K162381: HG PRO XP Nitrile Powder Free Examination Gloves Tested for Use with Chemotherapy Drugs.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K162381

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026